Anticoagulation: weight-adjusted heparin dosing was effective.
|
|
|
Clinical bottom line (level 1b)
-
Using a weight-based nomogram for heparin dosing produced therapeutic levels or higher, sooner than the standard method
(NNT =
2
at 6
hours)
(NNT =
5
at 24
hours)
.
-
Using a weight-based nomogram was no better than the standard method for getting within therapeutic range for 24 hours.
-
There was no clear difference in bleeding rates.
-
Patients on the weight-based nomogram had fewer recurrent DVTs
(NNT =
5
at 3
months)
.
|
|
Raschke et al:
Annals of Internal Medicine
1993;
119 (9):
874-881
|
Expires
June 2003
|
The study
Double-blinded concealed randomised
trial
without
intention-to-treat
Setting: two teaching hospitals, USA
115 patients
(aged
?,
?%
male)
proven deep vein thrombosis or pulmonary embolism (85), unstable angina (25), acute peripheral arterial ischaemia (2), crescendo ischaemic attacks (2)
Excluded if
anticoagulated or thrombolysed in last seven days
active haemorrhage
acute major cerebrovascular accidents
history of heparin-induced thrombocytopenia
known heparin allergy
Control Group: (n = 53, 53 analysed):
standard care nomogram- initially- 5000 unit bolus, then 100 units/hr: aPTT <1.2- 5000 unit bolus, then 200 units/hr: aPTT 1.2-1.5- 2500 units bolus, then 100 units/hr: aPTT 1.5-2.3- no change: aPTT 2.3-3.0- decrease rate by 100 units/hr: aPTT >3.0- stop infusion for one hour, then decrease rate by 200 units/hr
Experimental Group: (n = 62, 62 analysed):
weight-based nomogram- initially- 80 unit/kg bolus, then 18 units/kg/hr: aPTT <1.2- 60 units/kg bolus, then increase by 4 units/kg/hr: aPTT-1.2-1.5- 40 unit/kg bolus, then increase 2 units/kg/hr: aPTT 1.5-2.3- no change: aPTT 2.3-3.0- decrease rate by 2 units/kg/hr: aPTT >3.0- stop infusion for 1 hour, then decrease rate by 3 units/kg/hr
Nurses performed dosing according to protocol- aPTT levels recorded six hours after every change. Warfarin was withheld for 48 hours. Patients and physicians were blinded to regimen used.
100% followed for
3
months
Outcome notes:
-
major bleed
: overt bleed and: >2 g/dl drop; transfusion of two plus units; location of haemorrhage in retroperitoneum, cranium or prosthetic joint
-
minor discharge
: overt bleed and none of the major bleed factors
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| first aPTT on treatment >1.5 x control
|
6
hours |
17 (32.1%) |
53 (85.5%) |
-167% (-300% to
-78%) |
-53.4% (-68.7% to
-38.1%) |
2
(1 to
3)
|
| aPTT >1.5
|
24
hours |
41 (77.4%) |
60 (96.8%) |
-25% (-46% to
-7%) |
-19.4% (-31.5% to
-7.32%) |
5
(3 to
14)
|
| aPTT 1.5-2.3
|
24
hours |
40 (75.5%) |
55 (88.7%) |
-18% (-40% to
2%) |
-13.2% (-27.3% to
0.77%) |
8
(NNT = 4 to infinity;
NNH =
130
to infinity)
|
| major bleed
|
unknown |
2 (3.77%) |
2 (3.23%) |
15% (-486% to
88%) |
0.55% (-6.21% to
7.31%) |
180
(NNT = 13 to infinity;
NNH =
16
to infinity)
|
| minor discharge
|
unknown |
1 (1.89%) |
0 (0.00%) |
100% (% to
%) |
1.89% (-1.78% to
5.55%) |
53
(NNT = 18 to infinity;
NNH =
56
to infinity)
|
| recurrent DVT
|
3
months |
8 (25.0%) |
2 (4.88%) |
80% (14% to
96%) |
20.1% (3.73% to
36.5%) |
5
(3 to
27)
|
| Outcome |
Control Group (SD) |
Experimental Group (SD) |
Mean Difference (95% CI) |
| time to reach aPTT 1.5-2.3
|
22.3
()
|
14.1
()
|
p=0.003
( to )
|
For recurrent DVT, only 32 patients in the control group and 41 in the experimental group were available for analysis.
Comments
- The study is too small to show any effect on bleeding.
Citation
-
Raschke
RA,
Reilly
BM,
Guidry
JR, et al:
The weight-based heparin dosing nomogram compared with a 'standard care' nomogram: a randomized controlled trial.
Annals of Internal Medicine
1993;
119 (9):
874-881
Search Terms:
anticoagulation in Best Evidence
Contributor: Chris Ball and Clare Wotton,
June 2000
Reviewer:
Clinical Question.
| Patient |
DVT or PE, unstable angina, acute peripheral arterial ischaemia, crescendo ischaemic attacks |
| Intervention or Exposure |
weight-based nomogram |
| Comparison |
standard care nomogram |
| Outcome |
bleeding |
|
|